<p>If signs of virilisation develop, discontinuation of the treatment should be considered, Preferably in consultation with the patient.<br />
<br />
It is recommended to monitor patients with any of the following conditions:</p>

<ul>
	<li>latent or overt cardiac failure, renal dysfunction, hypertension or migraine (or a history of these conditions), since anabolic steroids may occasioally induce fluid retention:</li>
	<li>incomplete statural growth, since anabolic steroids in high dosages may accelerate epiphyseal closure;</li>
	<li>skeletal metastases of breast carcinoma. In these patients</li>
	<li>hypercalcaemia may develop both spontaneously and as a result of anabolic steroid therapy. The later can be indicative of a positive tumour response to the hormonal treatment. Nevertheless, the hypercalcaemia should first be treated appropriately and after restoration of normal calcium levels hormone therapy can be resumed;</li>
	<li>liver dysfunction.</li>
</ul>

<p>The use of anabolic steroids to enhance athletic ability may carry severe risks to the user&#39;s health and should be discouraged.</p>